Precision Neuroscience, a New York City-based developer of brain-computer interfaces, raises $250 million in a Series D round at a valuation above $1 billion. The financing brings its total funding to $430 million. Bill Ackman's backing places him alongside Elon Musk and Jeff Bezos as investors entering the emerging brain-computer interface industry.
Sep 2026 · New York TimesNews article
Precision Neuroscience Closes Oversubscribed $250M Series Dglobenewswire.com/news-release/2026/09/24/3368254/0/en/precision-neuroscience-closes-oversubscribed-250m-series-d-led-by-pershing-square-inc-the-ackman-oxman-institute-and-a-leading-life-sciences-investment-fund.html
Precision Neuroscience, a brain-computer interface (BCI) company, closes an oversubscribed $250 million Series D financing co-led by Pershing Square, the Ackman Oxman Institute, and a leading life sciences investment fund. The round values the company at just over $1 billion.
Precision Neuroscience and UChicago Medicine launch a clinical partnership to study AI-driven sensorimotor function and neuroprosthetics using Layer 7. The collaboration advances brain-computer interface research.
Precision Neuroscience appoints Craig Mermel as chief AI and data officer, where he leads the company’s artificial intelligence and data strategy. His responsibilities also include development of its neural dataset.
